KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Non-Current Deferred Tax Liability (2021 - 2022)

Historic Non-Current Deferred Tax Liability for Pacific Biosciences Of California (PACB) over the last 2 years, with Q4 2022 value amounting to $835000.0.

  • Pacific Biosciences Of California's Non-Current Deferred Tax Liability fell 35.8% to $835000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $835000.0, marking a year-over-year decrease of 35.8%. This contributed to the annual value of $835000.0 for FY2022, which is 35.8% down from last year.
  • According to the latest figures from Q4 2022, Pacific Biosciences Of California's Non-Current Deferred Tax Liability is $835000.0, which was down 35.8% from $838000.0 recorded in Q4 2021.
  • In the past 5 years, Pacific Biosciences Of California's Non-Current Deferred Tax Liability registered a high of $838000.0 during Q4 2021, and its lowest value of $835000.0 during Q4 2022.